Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal Cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2021.06.032 ◽

2021 ◽

Author(s):

Floor J. Backes ◽

Lai Wei ◽

Min Chen ◽

Kasey Hill ◽

Kyle Dzwigalski ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Weekly Paclitaxel ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Part I of GANNET53: A multicenter phase I/II trial of the Hsp90 inhibitor ganetespib (G) combined with weekly paclitaxel (P) in women with high-grade serous, high-grade endometrioid, or undifferentiated, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.5578 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5578-5578

Author(s):

Isabelle Ray-Coquard ◽

Ioana Braicu ◽

Regina Berger ◽

Sven Mahner ◽

Jalid Sehouli ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Hsp90 Inhibitor ◽

Weekly Paclitaxel ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Multicenter Phase ◽

Platinum Resistant

Download Full-text

Phase II results of GANNET53: A European multicenter phase I/randomized II trial of the Hsp90 inhibitor Ganetespib (G) combined with weekly Paclitaxel (P) in women with high-grade serous, high-grade endometrioid, or undifferentiated, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.5567 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 5567-5567 ◽

Author(s):

Nicole Concin ◽

Ioana Braicu ◽

Pierre Combe ◽

Isabelle Laure Ray-Coquard ◽

Florence Joly ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Phase Ii ◽

Hsp90 Inhibitor ◽

Weekly Paclitaxel ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Multicenter Phase ◽

Platinum Resistant

Download Full-text

Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2019.04.057 ◽

2019 ◽

Vol 154 ◽

pp. 23

Author(s):

F.J. Backes ◽

L. Wei ◽

D.E. Cohn ◽

R. Salani ◽

J.L. Hays ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Weekly Paclitaxel ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Phase I results of GANNET53: A multicenter phase I/II trial of the Hsp90 inhibitor ganetespib (G) combined with weekly paclitaxel (P) in women with high-grade serous, high-grade endometrioid, or undifferentiated, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e17038 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e17038-e17038 ◽

Author(s):

Nicole Concin ◽

Ioana Braicu ◽

Regina Berger ◽

Sven Mahner ◽

Jalid Sehouli ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Hsp90 Inhibitor ◽

Weekly Paclitaxel ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Multicenter Phase ◽

Platinum Resistant

Download Full-text

Abstract CT091: Phase I study of intraperitoneal TRX-E-002-1 in patients with persistent or recurrent ovarian cancer, fallopian tube cancer or primary peritoneal cancer: Results of dose-escalation phase

10.1158/1538-7445.am2019-ct091 ◽

2019 ◽

Author(s):

Jermaine Coward ◽

Don Dizon ◽

Ganessan Kichenadasse ◽

Paul Harnett ◽

Kathleen Moore ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Fallopian Tube ◽

Dose Escalation ◽

Phase I Study ◽

Recurrent Ovarian Cancer ◽

Fallopian Tube Cancer ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Abstract CT091: Phase I study of intraperitoneal TRX-E-002-1 in patients with persistent or recurrent ovarian cancer, fallopian tube cancer or primary peritoneal cancer: Results of dose-escalation phase

10.1158/1538-7445.sabcs18-ct091 ◽

2019 ◽

Author(s):

Jermaine Coward ◽

Don Dizon ◽

Ganessan Kichenadasse ◽

Paul Harnett ◽

Kathleen Moore ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Fallopian Tube ◽

Dose Escalation ◽

Phase I Study ◽

Recurrent Ovarian Cancer ◽

Fallopian Tube Cancer ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Phase I trial of the anti-idiotypic monoclonal antibody (mAb) ACA-125 in patients with epithelial ovarian, fallopian tube or primary peritoneal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.5018 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5018-5018

Author(s):

P. Sabbatini ◽

C. Aghajanian ◽

J. Dupont ◽

F. Derosa ◽

S. Anderson ◽

...

Keyword(s):

Monoclonal Antibody ◽

Phase I ◽

Fallopian Tube ◽

Phase I Trial ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

ICON8: An international randomized trial comparing two dose-dense regimens, 3-weekly carboplatin plus weekly paclitaxel (CwT), and weekly carboplatin-paclitaxel (wCwT), to standard 3-weekly treatment in women with newly diagnosed ovarian, fallopian tube, and primary peritoneal cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps5611 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS5611-TPS5611 ◽

Author(s):

Jane Hook ◽

Sally Patricia Stenning ◽

James Brenton ◽

Stan B Kaye ◽

Iain A. McNeish ◽

...

Keyword(s):

Randomized Trial ◽

Fallopian Tube ◽

Weekly Paclitaxel ◽

Newly Diagnosed ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Weekly Treatment ◽

Download Full-text

Saracatinib (AZD0530) plus weekly paclitaxel in platinum resistant ovarian, fallopian tube or primary peritoneal cancer

http://isrctn.org/> ◽

10.1186/isrctn32163062 ◽

2012 ◽

Author(s):

Lee Webber

Keyword(s):

Fallopian Tube ◽

Weekly Paclitaxel ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Platinum Resistant

Download Full-text

Phase I Study of Abagovomab in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-05-2670 ◽

2006 ◽

Vol 12 (18) ◽

pp. 5503-5510 ◽

Author(s):

Paul Sabbatini ◽

Jakob Dupont ◽

Carol Aghajanian ◽

Felicia Derosa ◽

Elizabeth Poynor ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Phase I Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text